BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Gong Y, Zhang H, Etobayeva I, Miernikiewicz P, Luo D, Li X, Zhang X, Dąbrowska K, Nelson DC, He J, Wei H. ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain. Antimicrob Agents Chemother 2019;63:e02043-18. [PMID: 30642930 DOI: 10.1128/AAC.02043-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Caflisch KM, Suh GA, Patel R. Biological challenges of phage therapy and proposed solutions: a literature review. Expert Rev Anti Infect Ther 2019;17:1011-41. [PMID: 31735090 DOI: 10.1080/14787210.2019.1694905] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
2 Zhou B, Zhen X, Zhou H, Zhao F, Fan C, Perčulija V, Tong Y, Mi Z, Ouyang S. Structural and functional insights into a novel two-component endolysin encoded by a single gene in Enterococcus faecalis phage. PLoS Pathog 2020;16:e1008394. [PMID: 32176738 DOI: 10.1371/journal.ppat.1008394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Li X, Wang S, Nyaruaba R, Liu H, Yang H, Wei H. A Highly Active Chimeric Lysin with a Calcium-Enhanced Bactericidal Activity against Staphylococcus aureus In Vitro and In Vivo. Antibiotics (Basel) 2021;10:461. [PMID: 33921682 DOI: 10.3390/antibiotics10040461] [Reference Citation Analysis]
4 Shang X, Nelson DC. Contributions of Net Charge on the PlyC Endolysin CHAP Domain. Antibiotics (Basel) 2019;8:E70. [PMID: 31142020 DOI: 10.3390/antibiotics8020070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yang H, Luo D, Etobayeva I, Li X, Gong Y, Wang S, Li Q, Xu P, Yin W, He J, Nelson DC, Wei H. Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity. Antimicrob Agents Chemother 2020;64:e01610-19. [PMID: 31767724 DOI: 10.1128/AAC.01610-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Binte Muhammad Jai HS, Dam LC, Tay LS, Koh JJW, Loo HL, Kline KA, Goh BC. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci. Front Microbiol 2020;11:574739. [PMID: 33324362 DOI: 10.3389/fmicb.2020.574739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Luo D, Huang L, Gondil VS, Zhou W, Yang W, Jia M, Hu S, He J, Yang H, Wei H. A Choline-Recognizing Monomeric Lysin, ClyJ-3m, Shows Elevated Activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 2020;64:e00311-20. [PMID: 32958710 DOI: 10.1128/AAC.00311-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]